{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:51:31Z","timestamp":1787032291122,"version":"build-2736575974"},"reference-count":33,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The Japanese Society of Hepato-Biliary-Pancreatic Surgery guidelines propose a classification scheme that differs from the Union for International Cancer Control (UICC) system, in which the anatomic U-P point is the boundary between intrahepatic cholangiocarcinoma and perihilar cholangiocarcinoma (PCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To investigate whether this classification system improves clinicopathologic and genomic differentiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Fifty-eight PCC cases defined by the UICC system were collected and classified into intrahepatic PCC (IPCC) and extrahepatic PCC (EPCC) categories using U-P point division. They were analyzed by next-generation sequencing using a panel that targeted 425 cancer-related genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>The IPCC group exhibited a significantly larger tumor size compared with the EPCC group (4.67 \u00b1 2.44 cm versus 2.50 \u00b1 0.91 cm, P = .002). The mutation frequency of the KRAS proto-oncogene, GTPase (KRAS) Q61 was also significantly higher in the IPCC group than in the EPCC group (16.7% versus 0.0%, P = .03). There were no statistically significant differences in other pathologic features or genomic characteristics, including tumor mutation burden and microsatellite instability. Significant differences in gene mutation rates, such as phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA; 0.0% versus 15.8%, P = .01) and tumor protein p53 (TP53; 34.5% versus 63.2%, P = .04), were observed between PCC and adjacent biliary tract cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>This study offers valuable insight into the clinicopathologic and genomic features of PCC. It is proposed that the U-P point division may have limited potential to refine the characterization of PCC regarding these features, and that the UICC classification system can readily demonstrate the molecular specificity of PCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2023-0547-oa","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T20:01:54Z","timestamp":1722542514000},"page":"439-447","source":"Crossref","is-referenced-by-count":1,"title":["Pathologic and Molecular Features of Perihilar Cholangiocarcinoma Based on U-P Point Division"],"prefix":"10.5858","volume":"149","author":[{"given":"Ying","family":"Xiao","sequence":"first","affiliation":[{"name":"From the Departments of Pathology (Xiao, Yang, Li, Yin), Liver ICU (Zhang), and Hepatopancreatobiliary Surgery (Xiang), Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijia","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Xiao, Yang, Li, Yin), Liver ICU (Zhang), and Hepatopancreatobiliary Surgery (Xiang), Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhong","family":"Xiang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Xiao, Yang, Li, Yin), Liver ICU (Zhang), and Hepatopancreatobiliary Surgery (Xiang), Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Xiao, Yang, Li, Yin), Liver ICU (Zhang), and Hepatopancreatobiliary Surgery (Xiang), Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Xiao, Yang, Li, Yin), Liver ICU (Zhang), and Hepatopancreatobiliary Surgery (Xiang), Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfang","family":"Yin","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Xiao, Yang, Li, Yin), Liver ICU (Zhang), and Hepatopancreatobiliary Surgery (Xiang), Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"suppl 1","key":"2025042419520315000_i1543-2165-149-5-439-b01","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.14086","article-title":"Clinical presentation, diagnosis and staging of cholangiocarcinoma","volume":"39","author":"Forner","year":"2019","journal-title":"Liver Int"},{"key":"2025042419520315000_i1543-2165-149-5-439-b02","first-page":"73","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017","edition":"8th ed"},{"issue":"3","key":"2025042419520315000_i1543-2165-149-5-439-b03","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jhbp.211","article-title":"Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition","volume":"22","author":"Miyazaki","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"7","key":"2025042419520315000_i1543-2165-149-5-439-b04","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/modpathol.2017.22","article-title":"Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas","volume":"30","author":"Akita","year":"2017","journal-title":"Mod Pathol"},{"issue":"8","key":"2025042419520315000_i1543-2165-149-5-439-b05","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"issue":"10","key":"2025042419520315000_i1543-2165-149-5-439-b06","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/PAS.0000000000001118","article-title":"Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns","volume":"42","author":"Sigel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"2025042419520315000_i1543-2165-149-5-439-b07","article-title":"Epidemiology of cholangiocarcinoma [published online September 9, 2023]","author":"Qurashi","journal-title":"Eur J Surg Oncol"},{"issue":"suppl 1","key":"2025042419520315000_i1543-2165-149-5-439-b08","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.14093","article-title":"Anatomical, histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Int"},{"issue":"6","key":"2025042419520315000_i1543-2165-149-5-439-b09","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"2025042419520315000_i1543-2165-149-5-439-b10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5858\/arpa.2022-0537-RA","article-title":"Cholangiocarcinoma: pathologic and molecular classification in the era of precision medicine","volume":"148","author":"Gopal","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"2025042419520315000_i1543-2165-149-5-439-b11","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/hep.31862","article-title":"Molecular characterization of biliary tract cancer predicts chemotherapy and programmed death 1\/programmed death-ligand 1 blockade responses","volume":"74","author":"Yoon","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"2025042419520315000_i1543-2165-149-5-439-b12","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1038\/s41598-023-39608-2","article-title":"Mutational landscape of cancer-driver genes across human cancers","volume":"13","author":"Sinkala","year":"2023","journal-title":"Sci Rep"},{"issue":"10","key":"2025042419520315000_i1543-2165-149-5-439-b13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"issue":"3","key":"2025042419520315000_i1543-2165-149-5-439-b14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.31829","article-title":"Genetic determinants of outcome in intrahepatic cholangiocarcinoma","volume":"74","author":"Boerner","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"2025042419520315000_i1543-2165-149-5-439-b15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat Genet"},{"issue":"13","key":"2025042419520315000_i1543-2165-149-5-439-b16","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-17-2310","article-title":"Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer patients","volume":"24","author":"Yang","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"15","key":"2025042419520315000_i1543-2165-149-5-439-b17","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"14","key":"2025042419520315000_i1543-2165-149-5-439-b18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"2025042419520315000_i1543-2165-149-5-439-b19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"2025042419520315000_i1543-2165-149-5-439-b20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"issue":"23","key":"2025042419520315000_i1543-2165-149-5-439-b21","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1093\/bioinformatics\/btu549","article-title":"FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution","volume":"30","author":"Newman","year":"2014","journal-title":"Bioinformatics"},{"issue":"suppl 2","key":"2025042419520315000_i1543-2165-149-5-439-b22","article-title":"CoNVEX: copy number variation estimation in exome sequencing data using HMM","volume":"14","author":"Amarasinghe","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"16","key":"2025042419520315000_i1543-2165-149-5-439-b23","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"2025042419520315000_i1543-2165-149-5-439-b24","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1158\/1078-0432.CCR-19-0585","article-title":"Comprehensive genomic profiling identifies novel genetic predictors of response to anti-PD-(L)1 therapies in non-small cell lung cancer","volume":"25","author":"Fang","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2025042419520315000_i1543-2165-149-5-439-b25","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/cam4.4561","article-title":"NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability","volume":"11","author":"Wang","year":"2022","journal-title":"Cancer Med"},{"issue":"746","key":"2025042419520315000_i1543-2165-149-5-439-b26","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn2694","article-title":"Functional and biological heterogeneity of KRAS Q61 mutations","volume":"15","author":"Huynh","year":"2022","journal-title":"Sci Signal"},{"key":"2025042419520315000_i1543-2165-149-5-439-b27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jss.2017.03.027","article-title":"Radiologic evaluation of vasculobiliary anatomy in the umbilical fissure","volume":"214","author":"Ji","year":"2017","journal-title":"J Surg Res"},{"issue":"9","key":"2025042419520315000_i1543-2165-149-5-439-b28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"2025042419520315000_i1543-2165-149-5-439-b29","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.21037\/jgo-21-776","article-title":"Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma","volume":"12","author":"Zheng","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"2025042419520315000_i1543-2165-149-5-439-b30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14728222.2021.2013801","article-title":"Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles","volume":"25","author":"Simbolo","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"2025042419520315000_i1543-2165-149-5-439-b31","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221128689","article-title":"Cholangiocarcinoma: molecular abnormalities and cells of origin","volume":"22","author":"Testa","year":"2023","journal-title":"Technol Cancer Res Treat"},{"issue":"9","key":"2025042419520315000_i1543-2165-149-5-439-b32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025042419520315000_i1543-2165-149-5-439-b33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.acr.2020.10.005","article-title":"Intrahepatic cholangiocarcinoma: morpho-molecular pathology, tumor reactive microenvironment, and malignant progression","volume":"149","author":"Sirica","year":"2021","journal-title":"Adv Cancer Res"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/5\/439\/3509704\/i1543-2165-149-5-439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/5\/439\/3509704\/i1543-2165-149-5-439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:39:48Z","timestamp":1764790788000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/5\/article-p439.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,2]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2023-0547-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}